This is a study involving patients with cancer who are referred by their treating physician for percutaneous locoregional therapies. Patient's clinical and radiology findings, pathology findings, survival, treatment responses, and complications after their locoregional therapy will be studied.
The efficacy of the percutaneous and transarterial treatments for solid tumors will be studied. Prospective study on patients who receive percutaneous locoregional therapies, including radiofrequency ablation (RFA), cryoablation, microwave ablation, IRE and chemical ablation for treatment of cancer will be performed. Preoperative clinic chart, procedure note, postoperative chart, pre- and post-operative CT, MRI or Ultrasound, angiographic findings, biopsy results and pathologic findings, will be reviewed. Patient survival, treatment responses, complications after the therapy will be collected from clinic visits and clinical encounters. Patient overall performance status before and after procedures will be assessed using the Quality of Life questionnaire (SF-36™ Health Survey).
Study Type
OBSERVATIONAL
Enrollment
26
Emory University Hospital
Altanta, Georgia, United States
Effect of percutaneous and transarterial treatments for cancer in quality of life
Patients will complete the QOL questionnare during their follow up visits after procedure. 1 month, 3 months, 6 months and 1 year.
Time frame: 1 year
response rate to percutaneous and transarterial treatment for cancer
Patients will be followed up 1, 3, 6 and 1year intervals after procedure.
Time frame: 1 month, 3 months, 6 months, 1 year.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.